canadianhealthpolicy.com

Latest Articles

The impact of innovative medicines on healthcare costs in Canada 1990 to 2024: $20 billion cumulative annual variation in spending on patent drugs saved $70 billion in overall public healthcare expenditure.

The impact of innovative medicines on healthcare costs in Canada 1990 to 2024: $20 billion cumulative annual variation in spending on patent drugs saved $70 billion in overall public healthcare expenditure.

Brett J Skinner, PhD | Founder and CEO, CHPI; Editor-in-Chief, CHPJ | ABSTRACT – Few

Reimbursement recommendations for new medicines in Canada: current trends in an uncertain era

Reimbursement recommendations for new medicines in Canada: current trends in an uncertain era

Nigel S. B. Rawson, PhD | Affiliated scholar/Senior fellow, Canadian Health Policy Institute, Macdonald-Laurier Institute,

Canada’s medication spending has been relatively low; may need to be reconsidered because of US “most-favored nation” pharma pricing policy

Canada’s medication spending has been relatively low; may need to be reconsidered because of US “most-favored nation” pharma pricing policy

Gerry Jeffcott | 3Sixty Public Affairs | ABSTRACT – Background: Public discourse often frames innovative

information and ideas for better healthcare

1 CHPI 1080

ISSN 2562-9492